PDA Letter Article

2021 PDA Honor Awards: Distinguished Service Awards

by PDA, Inc.

This is the second installment of the PDA Letter's series featuring the winners of the 2021 Honor Awards, which were presented at the Honor Awards Ceremony at the 2022 PDA Annual Meeting. PDA thanks all of the recipients for their contributions to the Association.

Featured below are the winners of the Distinguished Service Award. Next time: Service Appreciation Award.

Distinguished Service Awards

Four to six awards are typically given in recognition of volunteers' special acts, contributions, or service over the last year that have contributed to the success and strength of PDA. Examples of the types of activities that are recognized include service as members and leaders of PDA Program Planning committees, Task Forces, Interest Groups, and Chapters.

Tiffany Baker

Tiffany Baker 

Tiffany Baker is a Senior Consultant at ValSource, LLC, specializing in development and implementation of innovative approaches to quality risk management (QRM), QRM program design, creating a risk-focused culture, and developing risk-based approaches to support contamination control strategies. She is an active member of the Parenteral Drug Association (PDA), a faculty member for PDA’s Training Research Institute, and an instructor for the PDA courses on quality risk management foundations, practical application of QRM tools, and QRM for the design, qualification, and operation of manufacturing systems. She is co-lead for the PDA Task force on remote audits and inspections. She has a BS in microbiology from the University of Rhode Island and an MBA from Providence College

Emily Cheah, PhD

Emily Cheah 

Emily is one of the founding members of the PDA Singapore Chapter and has served as a Board Member in various capacities since its inception in 2013. A pharmacist by training, Emily is currently the Managing Director of Charles River Laboratories Singapore (Microbial Solutions). Emily oversees strategic technical operations including laboratory operations, QA, R&D / Centre of Excellence, and market development operations. She is involved in the evaluation and implementation of new technology & services with the Microbial Solutions division. She also serves on various committees within the company. She received her Ph.D. (Pharm. Technology) from the National University of Singapore and her EMBA from INSEAD.

Ann McGee

Ann McGee 

Ann chose the pharmaceutical industry as her career path as she had a driving desire to make a difference in influencing the quality of medicines in the interest of patient care and public health. Thirty-five years later, with experience as a pharmacist in industry, as a regulator and as a consultant, this core value still drives her. Ann has been involved in the PDA Ireland Chapter almost since its inception. She has served as Treasurer, Secretary, Vice President and most recently as President.

Friedrich von Wintzingerode, PhD

Friedrich von Wintzingerode 

Friedrich is QC Lead of the iNeST (individualized Neoantigen Specific Therapy) program at Roche-Genentech. Friedrich joined Roche-Genentech after earning his PhD in Microbiology and has over 20 years of experience in Quality Control and Quality Assurance in the biopharmaceutical industry, working on various topics including microbiological testing, material specifications, environmental monitoring, cleaning analytics, and analytics for release. Friedrich has led several global technical teams (e.g. microbial identification, microbiological testing, endotoxin testing, and Low Endotoxin Recovery/LER) at Roche-Genentech. He co-chaired the PDA Low Endotoxin Recovery Task Force, which authored PDA Technical Report No 82 on LER. He is also a member of the PDA ATMP advisory board. 

Eva Urban

Eva Urban 

Eva M. Urban is a Quality Professional with 25+ years of experience in various functions –operations and quality- within multi-national biopharmaceutical and biotech industries. Currently working in Global Quality Risk Management at CSL Behring. Eva is a member of the PDA RAQAB (Regulatory and Advisory Board), Chair of the working group for the IPEC/PDA Technical Report “Formalized Risk Assessment for Excipients”, Coordinator for the PDA Interest Group Quality Risk Management, a Member of the PDA Quality System Interest Group Steering Committee, and a Planning Committee Member for PDA Conferences including the Remote Audits and Inspections Workshop. 

Tia Tavares

Tita Tavares 

Tita Tavares is the Director of the Washington, DC Office for Azzur Group. She is an engaged business and operations professional with over 10 years of experience working in the pharmaceutical industry and GxP environments to positively influence the implementation of best practices related to efficiency and compliance. In 2022, her primary business focus will be the rollout of a holistic and comprehensive Data Integrity Program Initiative that speaks to the mitigation and causes of data inconsistencies and the overall health of an organization’s quality culture. Tita volunteers with the PDA Capital Area Chapter and the PDA Chapter Council.